1. Home
  2. KRRO vs IMRX Comparison

KRRO vs IMRX Comparison

Compare KRRO & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

SELL

Current Price

$12.67

Market Cap

196.4M

Sector

Health Care

ML Signal

SELL

Logo Immuneering Corporation

IMRX

Immuneering Corporation

SELL

Current Price

$3.53

Market Cap

232.3M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
KRRO
IMRX
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
232.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
KRRO
IMRX
Price
$12.67
$3.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
7
Target Price
★ $21.50
$17.00
AVG Volume (30 Days)
212.2K
★ 714.9K
Earning Date
11-05-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.75
EPS
N/A
★ N/A
Revenue
★ $6,392,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 181.46
N/A
52 Week Low
$5.20
$3.35
52 Week High
$17.35
$8.48

Technical Indicators

Market Signals
Indicator
KRRO
IMRX
Relative Strength Index (RSI) 48.28 43.73
Support Level $11.81 $3.37
Resistance Level $14.47 $5.32
Average True Range (ATR) 1.45 0.27
MACD -0.22 0.02
Stochastic Oscillator 24.60 26.09

Price Performance

Historical Comparison
KRRO
IMRX

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: